Archive 1995–2023
2000, volume 16, issue 3
Article
Farmakologiczne leczenie spastyczności w przebiegu stwardnienia rozsianego
Farmakoterapia w Psychiatrii i Neurologii, 2000, 3, 275-283
Summary
Multiple sclerosis is common neurological entity and spasticity is widespread and debilitating condition affecting quality of life of MS patients. While not all cases of spasticity need to be, or even should be, treated, the physician now has available a wide range of potentially effective treatments. Strengths and weaknesses of each option play an important role in treatment decision-making.